Pulse Biosciences, Inc (PLSE): Price and Financial Metrics


Pulse Biosciences, Inc (PLSE): $16.90

-0.51 (-2.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PLSE Stock Price Chart Interactive Chart >

Price chart for PLSE

PLSE Price/Volume Stats

Current price $16.90 52-week high $45.82
Prev. close $17.41 52-week low $8.76
Day low $16.82 Volume 41,029
Day high $17.41 Avg. volume 112,098
50-day MA $18.90 Dividend yield N/A
200-day MA $20.61 Market Cap 447.17M

Pulse Biosciences, Inc (PLSE) Company Bio


Pulse Biosciences, a development stage medical device company, focuses on developing medical technologies based on sub-microsecond pulsed electric field technology to detect and treat skin cancer and enhance wound healing. The company was founded in 2014 and is based in Burlingame, California.


PLSE Latest News Stream


Event/Time News Detail
Loading, please wait...

PLSE Latest Social Stream


Loading social stream, please wait...

View Full PLSE Social Stream

Latest PLSE News From Around the Web

Below are the latest news stories about Pulse Biosciences Inc that investors may wish to consider to help them evaluate PLSE as an investment opportunity.

Moving Average Crossover Alert: Pulse Biosciences (PLSE)

Pulse Biosciences (PLSE) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

Yahoo | June 11, 2021

New Strong Sell Stocks for June 9th

FLY, PLSE, YTRA, GHL, and TELL have been added to the Zacks Rank #5 (Strong Sell) List on June 9, 2021.

Yahoo | June 9, 2021

Pulse Biosciences Announces Health Canada Approval for CellFX® System

Pulse Biosciences Announces Health Canada Approval for CellFX ® System - Company to Expand Global Controlled Launch Program with Clinical Aesthetic Experts in Canada.

BioSpace | June 8, 2021

Pulse Biosciences to Participate in the Jefferies Healthcare Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company introducing the CellFX System powered by Nano-Pulse Stimulation (NPS) technology, today announced plans to participate in the Jefferies Virtual Healthcare Conference. Management is scheduled to present at 12:30pm PT on Wednesday, June 2, 2021.

BioSpace | May 23, 2021

Pulse Biosciences Presents Clinical Study Results of Nano-Pulse Stimulation Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company introducing the CellFX System powered by Nano-Pulse Stimulation (NPS) technology, today announced the podium presentation of four clinical studies of NPS technology at the American Society for Laser Medicine and Surgery (ASLMS) Virtual Annual Meeting taking place on May 15-16, 2021. Recent results will be presented on

Wallstreet:Online | May 13, 2021

Read More 'PLSE' Stories Here

PLSE Price Returns

1-mo -4.14%
3-mo -28.33%
6-mo -23.56%
1-year 57.80%
3-year 3.74%
5-year 286.73%
YTD -29.17%
2020 77.93%
2019 17.02%
2018 -51.44%
2017 263.08%
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7619 seconds.